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PURPOSE: To compare salivary and serum cortisol levels, salivary alpha-amylase (sAA), and unstimulated whole saliva 
(UWS) flow rate in pregnant and non-pregnant women. METHOD: A longitudinal study was conducted at a health 
promotion center of a university hospital. Nine pregnant and 12 non-pregnant women participated in the study. Serum 
and UWS were collected and analyzed every trimester and twice a month during the menstrual cycle. The salivary 
and serum cortisol levels were determined by chemiluminescence assay and the sAA was processed in an automated 
biochemistry analyzer. RESULTS: Significant differences between the pregnant and non-pregnant groups were found 
in median [interquartile range] levels of serum cortisol (23.8 µL/dL [19.4–29.4] versus 12.3 [9.6–16.8], p<0.001) 
and sAA (56.7 U/L [30.9–82.2] versus 31.8 [18.1–53.2], p<0.001). Differences in salivary and serum cortisol 
(µL/dL) and sAA levels in the follicular versus luteal phase were observed (p<0.001). Median UWS flow rates were 
similar in pregnant (0.26 [0.15–0.30] mL/min) and non-pregnant subjects (0.23 [0.20–0.32] mL/min). Significant 
correlations were found between salivary and serum cortisol (p=0.02) and between salivary cortisol and sAA (p=0.01). 
CONCLUSIONS: Serum cortisol and sAA levels are increased during pregnancy. During the luteal phase of the ovarian 
cycle, salivary cortisol levels increase, whereas serum cortisol and sAA levels decline.
Resumo
OBJETIVO: Comparar os níveis de cortisol sérico e salivar, alfa-amilase salivar (sAA) e fluxo de saliva não estimulada (UWS) 
em gestantes e não gestantes. MÉTODOS: Trata-se de um estudo longitudinal realizado no centro de promoção da saúde 
de um hospital universitário. Nove gestantes e 12 não gestantes participaram do estudo. Foram coletados e analisados soro 
e UWS nos três trimestres gestacionais e duas vezes por mês durante o ciclo menstrual. A análise do cortisol salivar e sérico 
foi realizada com o uso de quimiluminescência e a atividade da sAA foi determinada por meio de analisador automático 
para bioquímica. RESULTADOS: Foi verificado que a mediana (intervalo interquartil) dos níveis de cortisol sérico no grupo 
de gestantes foi maior que 23,8 µL/dL (19,4–29,4) quando comparado ao grupo de não gestantes, que teve média de 
12,3 (9,6–16,8; p<0,001). Os níveis de sAA seguiram o mesmo padrão, com médias de 56,7 U/L (30,9–82,2) e 
31,8 (18,1–53,2; p<0,001), respectivamente. Foram observadas diferenças dos níveis de cortisol sérico e salivar (µL/dL) 
e de sAA entre a fase folicular versus a fase lútea (p<0,001). As medianas dos fluxos salivares (UWS) foram semelhantes 
em gestantes (0,26 [0,15–0,30] mL/min) e não gestantes (0,23 [0,20–0,32] mL/min). Foram encontradas correlações 
significativas entre o cortisol salivar e o sérico (p=0,02) e entre o cortisol salivar e a sAA (p=0,01). CONCLUSÕES: 
Os níveis de cortisol sérico de sAA durante a gestação elevam-se. Na fase lútea do ciclo ovariano, os níveis de cortisol 
salivar aumentam ao passo que os níveis de cortisol sérico e sAA diminuem.
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Introduction
Laboratory analysis of saliva has become an important 
technique for the assessment of physiological and patho-
logical conditions, mostly due to the origin, composition, 
and functions of saliva, as well as its interactions with other 
body systems and structures. Other favorable aspects of 
saliva testing include painless sampling, ease of storage, and 
low cost of analysis as compared with blood. These factors 
have driven extensive research into this testing modality1-3, 
including validation studies of quantitation of a variety 
of organic and inorganic compounds in saliva4.
Cortisol is a hormone secreted by the adrenal 
glands that can be detected in urine, serum, and saliva. 
Measurement of cortisol levels in saliva is gaining in-
creasingly widespread acceptance as a diagnostic method 
because they correspond only to the unbound, bioactive 
fraction of cortisol, whereas most serum cortisol is bound 
to proteins such as corticosteroid-binding globulin 
(CBG)5,6. Salivary cortisol testing has been used to as-
sess hypothalamic-pituitary-adrenal (HPA) axis function 
under various cognitive conditions and in the presence of 
stress and anxiety6,7. During pregnancy, baseline salivary 
cortisol concentrations exhibit a constant increase start-
ing around gestational week 25; by term, levels are over 
twice as high as those detected in non-pregnant women8. 
Within one week after delivery, salivary cortisol levels 
returns to baseline8. The physiology of cortisol can be as-
sessed under baseline conditions and in response to specific 
stressors9,10. Measurement of changes in baseline cortisol 
levels and in cortisol reactivity to stress during pregnancy 
is important, as high concentrations of cortisol affect fetal 
development7,10,11 and may lead to low birth weight12. 
The enzyme salivary alpha-amylase (sAA) is one of the 
key protein constituents of saliva and accounts for 10–20% 
of all proteins produced by the parotid gland13. Its function 
includes, but is not restricted to, initiation of digestion in 
the oral cavity. It also plays a major role in modulation of 
bacterial adhesion and growth on intraoral surfaces14. Recent 
studies have highlighted the utility of sAA as a marker of 
physical, psychological, or psychosocial stress induced by 
activation of the autonomic nervous system, which controls 
the salivary glands13,15-17. Furthermore, increased levels of 
sAA have been shown to reduce the likelihood of concep-
tion during the fertile window in women18.
Pregnancy-related changes in sAA secretion have 
rarely been described in the literature. Studies suggest 
that salivary flow and sAA levels remain unchanged 
during gestation19,20. However, a research has also shown 
that pregnant women exposed to stressor agents exhibit 
increased sAA concentrations17; conversely, other study 
have demonstrated less marked changes in sAA levels in 
response to stress in pregnant versus non-pregnant subjects5.
Salivary cortisol and sAA have been used in medical 
and psychological research as physiological and psycho-
logical markers of psychosocial stress15,21-23. However, data 
on baseline sAA and cortisol levels during the menstrual 
cycle in humans are scarce, conflicting, and inconclusive 
in relation to changes during pregnancy5,19,20,24.
The aim of the present study was to measure 
serum and salivary cortisol levels, sAA and unstimu-
lated whole saliva (UWS) flow rate in pregnant and 
non-pregnant women and compare these levels during 
each trimester of pregnancy (in the pregnant group) 
and during the follicular and luteal phases of the ovar-
ian cycle (in the non-pregnant group). A secondary 
objective was to ascertain whether correlations exist 
between these variables.
Methods
Pregnant and non-pregnant women seen at Hospital 
Universitário da Universidade de Brasília, in Brasília, 
Brazil, were invited to take part in this longitudinal 
study. The criteria for inclusion common to both groups 
were good overall health, age >18 years, no history of 
miscarriage during the last 2 years, no current systemic 
pharmacotherapy, and no smoking. Pregnant subjects were 
required to be in the first trimester, and non-pregnant 
participants were required to refrain from hormonal con-
traceptive use. All participants underwent an intraoral 
examination, interview and history-taking, and blood and 
UWS collection in each trimester of pregnancy (for pregnant 
participants) and during the follicular and luteal phases 
of the menstrual cycle (for non-pregnant participants). 
The study was conducted according to the Declaration of 
Helsinki and all participants provided written informed 
consent approval by the Universidade de Brasília School 
of Medicine Research Ethics Committee (#040/07).
Case series and sample collection
In the pregnant group, first-trimester samples 
were collected between gestational weeks 11 and 16; 
second-trimester samples, between gestational weeks 18 
and 22; and third-trimester samples, between weeks 
32 and 36. All non-pregnant participants had regular 
cycles, and menstrual cycle phases were estimated on 
the basis of information provided during the interview. 
The self-reported date of onset of menses was used to 
calculate the follicular phase (6 to 8 days later) and 
luteal phase (23 to 25 days later).
Participants were instructed to arrive after at least 
8 hours of fasting and to have completed their routine 
oral hygiene within 2 hours before sample collection. 
Blood samples were collected first, between 7:00 and 
8:00 a.m., followed by UWS. Patients were seated on a 
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dental chair for 2 minutes to relax and then instructed 
to spit, so as to discard any detritus-containing saliva 
present in the oral cavity. This was defined as time 
point zero for collection. Participants remained seated, 
with eyes open and the neck and head flexed forward to 
facilitate “passive” flow of saliva, and were instructed 
to refrain from moving the tongue, cheeks, or lips. 
UWS was collected into a 50-mL Falcon® polypropylene 
tube. Overall collection time was 6 minutes. Samples 
exhibiting reddish discoloration (suggesting presence 
of blood) or cloudiness or turbidity (suggesting exces-
sive epithelial cell shedding) were discarded to prevent 
excessive variation in cortisol and sAA levels. The col-
lected samples were immediately sent for analysis. The 
UWS flow rate was expressed as volume of saliva/unit 
of time (mL/min).
Laboratory analysis of cortisol and sAA levels
For measurement of cortisol levels, saliva samples 
were centrifuged and the supernatant set aside for analysis. 
Cortisol levels in serum and saliva (µg/dL) were determined 
by chemiluminescence assay (Immulite 2000®, Siemens 
Medical Solutions Diagnostics, Los Angeles, CA, USA), 
using reagents and calibration materials provided by the 
manufacturer. A 10 µl aliquot of serum/saliva was used 
and the calibration curve ranged from 1–50 µg/dL for 
cortisol. For measurement of sAA (U/L), saliva samples 
were diluted in distilled water to a concentration of 
1:100 (1%) and processed in an Architect c8000® auto-
mated chemistry analyzer (Abbott Clinical Chemistry, 
Wiesbaden, Germany), using reagents and calibration 
materials provided by the manufacturer.
Statistical methods
The sample size was calculated for a two-sided test 
to have 80% power to detect a clinically significant mean 
(standard deviation) difference of 4.4 (3.5) µg/dL in sali-
vary cortisol between groups, based on previous study25,26. 
Alpha was set at 0.05. The total number of subjects to be 
recruited was 20. Nevertheless, it was assumed an attri-
tion rate of 30%, which is to be expected in a long-term 
study once pregnant women are susceptible to intercur-
rent conditions. Furthermore, it was also considered that 
non-pregnant subjects were asked to attend study visits 
repeatedly without any health reason, nor monetary in-
centive to do so. Hence, it was enrolled 26 participants.
Data were analyzed in the Statistical Package for 
the Social Sciences (SPSS® 20.0 for Windows, SPSS Inc., 
IBM Group, Chicago, USA). All tests were two-sided 
and the significance level was set at p<0.05. Initially, the 
Mann-Whitney U test was used to assess between-group 
differences (pregnant versus non-pregnant). Afterwards, 
within-group differences were assessed. Serum cortisol, 
sAA and UWS flow rate were compared among pregnancy 
trimesters by means of analysis of variance (ANOVA), 
while the Kruskal-Wallis test was used for comparison of 
salivary cortisol levels. Within-group differences between 
the follicular and luteal phases of the ovarian cycle in 
non-pregnant subjects were assessed with the Wilcoxon 
test (salivary cortisol, sAA, and UWS flow rate) or a 
dependent t-test (serum cortisol). Spearman correlation 
coefficients were calculated for sAA, UWS flow rate, and 
serum and salivary cortisol.
Results 
A total of 13 pregnant (primigravida) and 13 non-
pregnant women were enrolled. Three miscarriages and 
one dropout occurred in the pregnant group, and one 
control was lost to follow-up. Thus, 9 primigravidas with 
median age (interquartile range) of 28 years (25–31), and 
12 non-pregnant women aged 29 (27–32) took part in the 
study. A total of 27 and 24 samples were collected for each 
variable per group, respectively. There were no significant 
between-group differences in salivary cortisol levels. However, 
significant within-group differences in median (interquartile 
range) levels were found among the non-pregnant subjects, 
with values of 1.0 (1.0–1.05) µg/dL in the follicular phase 
of the ovarian cycle versus 1.1 (1.0–1.48) µg/dL in the luteal 
phase (p<0.001) (Figure 1).
Median serum cortisol levels were significantly dif-
ferent in the pregnant and non-pregnant groups (23.8 
[19.4–29.4] versus 12.3 [9.6–16.8] µg/dL, and also between 
follicular versus luteal phase (12.7 [10.2–18.7] versus 12.2 
































Figure 1. Between-group and within-group salivary cortisol.
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There were no differences in median UWS flow rate 
values between pregnant and non-pregnant subjects (0.26 
[0.15–0.30] versus 0.23 [0.20–0.32] mL/min), and no 
within-group differences among trimesters of pregnancy 
or between the follicular and luteal phases of the ovarian 
cycle (data not shown).
Levels of sAA were significantly different between 
the pregnant and non-pregnant groups (56.7 [30.9–82.2] 
versus 31.8 [18.1–53.2] U/L, p<0.001) and between the 
follicular and luteal phases in the non-pregnant group 
(p<0.001) (Figure 3).
Significant Spearman correlations were found be-
tween salivary and serum cortisol levels (p=0.02) and 
between salivary cortisol and sAA (p=0.01) (Table 1).
Discussion
Measurement of salivary cortisol levels has been widely 
used as an alternative to quantitation of this hormone in 
plasma or serum. Saliva samples are readily obtained and 
can be collected several times a day, allowing dynamic 
assessment of free cortisol secretion5,6. Circulating un-
bound cortisol is quickly transported to saliva by passive 
diffusion, to the extent that some studies report strong 
correlations between salivary cortisol levels and free (un-
bound) cortisol concentrations in plasma and serum6,26,27.
However, if salivary cortisol levels are to be used for 
diagnostic purposes in clinical practice, analytical meth-
ods must be standardized and cutoff values defined on 
the basis of normal population-wide control samples to 
serve as a reference range for testing. Research and retail 
laboratories should validate their salivary cortisol assays 
before making them available to clinicians2,28.
The interrelatedness between serum and salivary 
cortisol levels in non-pregnant women and men appears 
to be the same. However, women in the third trimester 
of pregnancy and those on oral contraceptives exhibit 
markedly increased serum cortisol levels, but near-normal 
salivary cortisol27.
The linear correlation between serum free cortisol 
and salivary cortisol is usually very strong, independent 
of changes in CBG concentrations, and similar across all 
groups: men, pregnant women, non-pregnant women, 
and oral contraceptive users27.
Conversely, some authors believe these parameters 
should be interpreted cautiously29,30, as salivary cortisol 
concentrations do not correlate linearly with serum levels 
in some cases. This nonlinearity in association between 
total salivary and serum cortisol may be attributable to 
the presence of CBG in plasma. CBG concentrations 
may be increased during oral contraceptive use and in 

























































Figure 2. Between-group and within-group serum cortisol.












Correlation coefficient 1.000 0.324* -0.351* -0.080
Sig. (2-tailed) – 0.020 0.011 0.575
Serum 
cortisol
Correlation coefficient 1.000 0.135 -0.155
Sig. (2-tailed) – 0.343 0.277
Alpha-
amylase
Correlation coefficient 1.000 0.010
Sig. (2-tailed) – 0.943
*Correlation is significant at the 0.05 level (2-tailed).
UWS: unstimulated whole saliva.
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This might explain the fact that, in the present study, 
salivary and serum cortisol levels were significantly corre-
lated from a statistical but not from a clinical standpoint. 
It bears stressing that blood and saliva sampling took 
place in a short period of time (30 minutes at most) so 
as to prevent circadian influences on measurement of the 
parameters of interest.
When both CBG and cortisol concentrations are in-
creased simultaneously, as in pregnancy, salivary cortisol 
levels appear to remain within normal limits, although 
above the baseline levels found in non-pregnant women31,32. 
Studies have shown that salivary cortisol levels increase 
gradually, eventually exceeding the upper limit of normal, 
during the second half of pregnancy8,26,33. In the present 
study, there were no significant between-group differences 
in salivary cortisol levels. Serum cortisol levels, however, 
were higher in pregnant versus non-pregnant women. 
These findings are consistent with the literature9,26,31,32.
In the present study, significant differences were 
found between salivary cortisol levels in the follicular 
and luteal phases of the ovarian cycle, with higher val-
ues found in the latter. A previous study also found that 
salivary cortisol response patterns were more evident in 
the luteal phase, although the subjects were exposed to 
psychosocial stress, unlike the participants of the present 
study, who were not subjected to any external stressors23. 
A review of the literature did not yield any evidence that 
would explain this difference.
It has been suggested that salivary free cortisol levels 
are independent of salivary flow2. Accordingly, salivary 
flow rate and salivary cortisol concentration were unre-
lated in the present sample. This makes salivary cortisol 
a good biomarker, as it is unaffected by salivation itself. 
Although measurement of stimulated saliva is useful for 
assessment of the functional capacity of the salivary glands, 
unstimulated saliva is the predominant form during most 
of the day as well as during sleep, and plays an important 
role in the maintenance of oral health24,34. Furthermore, 
research suggests that if analysis of the biochemical com-
ponents of saliva is to be feasible in outpatient clinical 
practice, whole27 and unstimulated28 saliva must be used; 
therefore, UWS was used in the present study.
Although salivary free cortisol has been proposed 
as a useful parameter for assessment of pituitary-adrenal 
function, an appropriate biomarker that reflects sym-
pathoadrenal medullary activity has yet to be found. 
In this context, sAA has been suggested as a potential 
parameter for determination of autonomic activity and, 
thus, a reliable and noninvasively quantifiable indicator of 
stress-related changes in the human body15. The salivary 
glands are innervated by sympathetic and parasympa-
thetic nerve fibers alike, so that salivary secretion occurs 
in response to neurotransmitter-mediated stimulation35. 
As this biomarker is produced locally in the oral cavity, 
it is found in high concentrations in saliva as compared 
with other markers, such as cortisol, which is a compo-
nent of blood serum, produced by the adrenal gland, 
and transported to the saliva via ultrafiltration in the 
salivary glands36.
There is no established correlation between sAA and 
salivary or blood levels of cortisol in the literature13,15. In the 
present study, salivary cortisol levels correlated with sAA. 
However, there was no correlation between sAA and serum 
cortisol. This may be attributable to production in differ-
ent sites18,22. Nevertheless, the potential interrelatedness 
between these two parameters warrants further investigation.
Prior studies diverge as to the sAA response to preg-
nancy. Comparison between UWS collected from pregnant 
and non-pregnant women showed increased sAA levels in 
the first and second trimesters of pregnancy as compared 
to near-term and non-pregnant women24. Other research, 
however, failed to find any significant differences in sAA 
concentrations during pregnancy19. Supporting this find-
ing, no significant changes in sAA levels during gesta-
tion were observed in the present study. However, sAA 
activity was increased in pregnant versus non-pregnant 
subjects. We also observed greater sAA activity in the 
luteal phase of the ovarian cycle as compared with the 
follicular phase. To the best of our knowledge, no other 
studies have assessed sAA levels during the distinct phases 
of the menstrual cycle. One previous study found high 
levels of sAA, but not of salivary cortisol, to be associated 
with a reduction in female fertility18. The mechanism 
whereby sAA might reduce fertility remains unknown18.
Measurement of salivary flow rate plays an important 
role in the interpretation of changes in salivary protein. 
However, a previous study showed that no association what-
soever exists between sAA activity and salivary flow rate37. 
In addition, authors have confirmed that sAA measurement 
can be performed without assessment of salivary flow, as the 
latter does not interfere with sAA activation22,38. The pres-
ent study found no correlation between sAA and salivary 
flow rate and no correlations between cortisol and sali-
vary flow rates measured in pregnant and non-pregnant 
women, which confirms that neither cortisol nor sAA levels 
are significantly altered as a function of salivary flow rate.
Nevertheless, some limitations of this study should 
be noted. The small sample size precludes generalization 
of findings to other populations. Furthermore, in the non-
pregnant group, the timing of ovarian cycle phases was 
estimated solely on the basis of self-provided information, 
and not evaluated by any tests.
However, in view of the foregoing, it is essential that 
investigators or clinicians be aware of potential differences 
attributable to distinct assay methodologies, to enable 
proper interpretation of reference ranges. Saliva-based 
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